MEDICINA
Departamento
Università di Perugia
Perugia, ItaliaPublicaciones en colaboración con investigadores/as de Università di Perugia (20)
2022
-
Guiding the global evolution of cytogenetic testing for hematologic malignancies
Blood, Vol. 139, Núm. 15, pp. 2273-2284
-
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
The Lancet Haematology, Vol. 9, Núm. 2, pp. e98-e110
-
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood, Vol. 140, Núm. 11, pp. 1229-1253
2021
-
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 11, pp. 785-798
2020
-
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
The Lancet, Vol. 396, Núm. 10262, pp. 1563-1573
2019
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
-
Maintenance Treatment and Survival in Patients with Myeloma: A Systematic Review and Network Meta-analysis
JAMA Oncology, Vol. 4, Núm. 10, pp. 1389-1397
2017
-
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma
British Journal of Haematology, Vol. 178, Núm. 4, pp. 571-582
2014
-
Research update for articles published in EJCI in 2012
European Journal of Clinical Investigation, Vol. 44, Núm. 10, pp. 1010-1023
2013
-
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials
Haematologica, Vol. 98, Núm. 6, pp. 980-987
2006
-
Characterization of a recurrent translocation t(2;3)(p15-22;q26) occurring in acute myeloid leukaemia
Leukemia, Vol. 20, Núm. 1, pp. 48-54
1997
-
del(7q) in chronic B-cell lymphoid malignancies
Cancer Genetics and Cytogenetics, Vol. 93, Núm. 2, pp. 147-151
1996
-
BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders
Genes Chromosomes and Cancer, Vol. 15, Núm. 1, pp. 38-47
-
Deletions of the long arm of chromosome 7 in myeloid disorders: Loss of band 7q32 implies worst prognosis
British Journal of Haematology, Vol. 92, Núm. 3, pp. 574-581
1995
-
Characterization by chromosome painting of balanced and unbalanced x chromosome translocations in myelodysplastic syndromes
Cancer Genetics and Cytogenetics, Vol. 82, Núm. 1, pp. 17-22
-
Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria
Leukemia, Vol. 9, Núm. 12, pp. 2140-2146
-
Fluorescence in situ hybridization identifies new chromosomal changes involving 3q27 in non‐Hodgkin's lymphomas with BCL6/LAZ3 rearrangement
Genes, Chromosomes and Cancer, Vol. 14, Núm. 1, pp. 1-7
-
Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): Clinical, cytogenetic and molecular studies
Leukemia, Vol. 9, Núm. 7, pp. 1162-1166